Your session is about to expire
← Back to Search
Palliative Care for Liver Transplant Candidates (ASPECT-Pilot Trial)
N/A
Waitlist Available
Led By Myrick C Shinall, MD, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
adult patients (age 18 years or greater) undergoing evaluation for liver transplantation at Vanderbilt University Medical Center
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
ASPECT-Pilot Trial Summary
This trial is testing whether a specialist palliative care intervention could help patients who are being evaluated for a liver transplant.
Who is the study for?
This trial is for adults over 18 being evaluated for liver transplantation at Vanderbilt University Medical Center. Participants must live in Tennessee, speak English fluently, have a telephone, and not be prisoners or deaf. They should not already be receiving specialist palliative care.Check my eligibility
What is being tested?
The study is testing the addition of specialist palliative care consultations to the standard process of evaluating patients for liver transplants. It aims to gather information to design a larger future trial on this approach.See study design
What are the potential side effects?
Since this trial involves consultations rather than medications or invasive procedures, traditional side effects are not expected. However, emotional or psychological distress from discussions about serious illness may occur.
ASPECT-Pilot Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult being evaluated for a liver transplant at Vanderbilt.
ASPECT-Pilot Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of Intervention
Appropriateness of Intervention
ASPECT-Pilot Trial Design
1Treatment groups
Experimental Treatment
Group I: Specialist Palliative CareExperimental Treatment1 Intervention
All patients will be assigned to receive the intervention, consisting of two outpatient palliative care visits at Vanderbilt University Medical Center (VUMC).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Palliative Care Consultation
2012
N/A
~300
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
850 Previous Clinical Trials
669,112 Total Patients Enrolled
Myrick C Shinall, MD, PhDPrincipal InvestigatorAssistant Professor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult being evaluated for a liver transplant at Vanderbilt.I am not fluent in English.I am currently receiving care focused on relieving my symptoms and improving my quality of life.I am deaf.
Research Study Groups:
This trial has the following groups:- Group 1: Specialist Palliative Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current vacancies in this research program?
"As confirmed by clinicaltrials.gov, this particular research endeavour is not presently seeking participants. First posted on March 31st 2022 and subsequently updated four days later, the trial does not have any openings at present; though there are 273 other trials with open recruitment spots currently available."
Answered by AI
Share this study with friends
Copy Link
Messenger